EVEXIAS IntegrativeSolutions: Weight Management
July 11
Obesity vs. Weight Management: Your Guide to GLP-1 Agonists
You’ve heard about Glucagon-like Peptide-1 (GLP-1) based therapies, but do you know the when, why, and how to prescribe them? Do you understand the differences among the formulation options and when to prescribe each? Leading expert in peptide therapeutics, bestselling author, and globally-renowned clinician, Dr. Jim LaValle will delve into how these therapies work, their potential benefits and drawbacks, and who might be a good candidate.
Understanding Peptides and GLP-1s
The human body communicate through a complex network of chemicals, including peptides. Peptides are short chains of amino acids, the building blocks of proteins. GLP-1 is a specific type of peptide hormone, naturally produced in the gut. It plays a crucial role in regulating blood sugar levels and appetite. In recent years, science has discovered that GLP-1 agonists–developed for the treatment of diabetes–also effectively addresses obesity and the disease’s dangerous impact on health. These medications come in injectable forms and stimulate GLP-1 receptors, leading to feelings of fullness and reduced appetite.
Although widely shown to be effective, GLP-1 agonists are not safe for all patients. As a practitioner, it is vitally important to understand when and how to prescribe these potent drugs in your practice as well as support patients in achieving their goals when GLP-1s are not recommended.
VIEW AGENDA
REGISTER NOW: Space is Limited
EVEXIAS HEALTH SOLUTIONS INTEGRATIVESOLUTIONS: WEIGHT MANAGEMENT
When: Thursday, July 11, 2024 | 8 AM CDT
Where: The Westin Hotel, 1200 E State Hwy 114, Southlake, TX 76092
Cost: $995*
*Special Pricing For Active EVEXIAS Partner Providers: $895 (VISIT EVEXIAS ONLINE for the discount code)